| For: | Wirasorn K, Ngamprasertchai T, Chindaprasirt J, Sookprasert A, Khantikaew N, Pakkhem A, Ungarereevittaya P. Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. World J Gastrointest Oncol 2013; 5(4): 81-87 [PMID: 23671735 DOI: 10.4251/wjgo.v5.i4.81] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v5/i4/81.htm |
| Number | Citing Articles |
| 1 |
Mehmet Zengin, Hüsniye Esra Paşaoğlu. The retrospective analysis of periampullary region tumors. Ortadoğu Tıp Dergisi 2020; 12(1) doi: 10.21601/ortadogutipdergisi.277284
|
| 2 |
Ming-Liang Wang, Zhang-Yan Ke, Shuai Yin, Chen-Hai Liu, Qiang Huang. The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review. Hepatobiliary & Pancreatic Diseases International 2019; 18(2) doi: 10.1016/j.hbpd.2018.11.001
|
| 3 |
Wiphawan Wasenang, Anucha Puapairoj, Chatri Settasatian, Siriporn Proungvitaya, Temduang Limpaiboon. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma. Pathology - Research and Practice 2019; 215(7) doi: 10.1016/j.prp.2019.152451
|
| 4 |
Aumkhae Sookprasert, Kosin Wirasorn, Jarin Chindaprasirt, Piyakarn Watcharenwong, Thanachai Sanlung, Siraphong Putraveephong. Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma. Recent Results in Cancer Research 2023; 219 doi: 10.1007/978-3-031-35166-2_8
|
| 5 |
Abdulrahman Y. Hammad, Nick G. Berger, Dan Eastwood, Susan Tsai, Kiran K. Turaga, Kathleen K. Christian, Fabian M. Johnston, Timothy M. Pawlik, T. Clark Gamblin. Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival. Annals of Surgical Oncology 2016; 23(S5) doi: 10.1245/s10434-016-5560-1
|
| 6 |
Nobuyuki Yanagisawa, Kiyomi Hana, Norihiro Nakada, Masaaki Ichinoe, Wasaburo Koizumi, Hitoshi Endou, Isao Okayasu, Yoshiki Murakumo. High expression of L‐type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas. Cancer Medicine 2014; 3(5) doi: 10.1002/cam4.272
|
| 7 |
Pirawan Poosekeaw, Chawalit Pairojkul, Banchob Sripa, Prakasit Sa Ngiamwibool, Sitthichai Iamsaard, Chadamas Sakonsinsiri, Raynoo Thanan, Piti Ungarreevittaya, Konradin Metze. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. PLOS ONE 2021; 16(11) doi: 10.1371/journal.pone.0259075
|
| 8 |
Timothy Kendall, Diletta Overi, Maria Guido, Chiara Braconi, Jesus Banales, Vincenzo Cardinale, Eugenio Gaudio, Bas Groot Koerkamp, Guido Carpino. Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma. JHEP Reports 2024; 6(6) doi: 10.1016/j.jhepr.2024.101067
|